Status | Study |
Recruiting |
Study Name: Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF Condition: Retinal Neovascularization Date: 2016-08-16 Interventions: Device: Gonioscopy Study of the trabecular structure by gonioscopy |
Not yet recruiting |
Study Name: Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN Condition: Proliferative Diabetic Retinopathy Date: 2015-12-09 Interventions: Drug: Aflibercept Intravitreal Aflibercept Injection 2.0 mg |
Recruiting |
Study Name: Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) Condition: Retinopathy of Prematurity Date: 2015-07-19 Interventions: Drug: Propranolol 0.2% eye drops Enrolled preterm newborns will receive propranolol as ophthalmic soluti |
Recruiting |
Study Name: Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Condition: Neovascularization Macular Degeneration Diabetic Retinopat Date: 2015-05-24 Interventions: Drug: ziv-aflibercept zaltrap injection Other Name: |
Recruiting |
Study Name: Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina Condition: Macular Edema Central Serous Chorioretinopathy Retinal Vei Date: 2014-03-06 Interventions: Device: Selective retinal pigment epithelium laser therapy using the R:GEN Laser System Patients receive |
Terminated |
Study Name: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization Condition: Choroidal Retinal Neovascularization Date: 2013-12-31 Interventions: Drug: Aflibercept Injection Aflibercept intravitreal injection |
Completed |
Study Name: Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature Condition: Retinopathy of Prematurity Date: 2013-12-10 Interventions: Drug: Propranolol eye drops All the enrolled preterm newbo |
Recruiting |
Study Name: PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy Condition: Proliferative Diabetic Retinopathy Date: 2013-12-03 Interventions: Drug: Intravitreal Ranibizumabe |
Completed |
Study Name: Squalamine for the Treatment in Proliferative Diabetic Retinopathy Condition: Retinal Neovascularization Date: 2013-01-14 Interventions: Drug: Squalamine Lactate ophthalmic solution 0.2% Patients will start with Squalamine one drop twice dai |
Recruiting |
Study Name: Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration Condition: Macular Degeneration Age-related Maculopathies Age-related Date: 2011-12-14 Interventions: Biological: rAAV.sFlt-1 1 x 10 |